Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1744 of 6351
-
New drug combo targets rare bladder cancer
Disease control Recruiting nowBackground: Small cell carcinoma of the bladder (SCCB) and other high-grade neuroendocrine tumors (HGNET) of the urinary tract are rare but aggressive cancers. Average survival for people diagnosed with SCCB or HGNET is about 1 year. Lurbinectedin and avelumab are drugs that are…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
AI-Powered ECG could spot silent heart weakness before It's too late
Diagnosis Stopped earlyA prospective, cluster-randomized, care-as-usual controlled trial to evaluate the impact of an ECG-based artificial intelligence (ECG-AI) algorithm to detect low left ventricular ejection fraction (LVEF) on diagnosis rates of LVEF ≤ 40% in the outpatient setting. The objective o…
Sponsor: Anumana, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 13:27 UTC
-
New blood test may spot hidden tumors in MEN1 patients
Diagnosis Recruiting nowMultiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disease with a high degree of penetrance (\>80% of patients). It is caused by the presence of the MEN1 mutation located on chromosome 11q13. The prevalence of this mutation is estimated at approximately 1/30,000.…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Can a smartphone help silence distressing voices? online self-help program tested for psychosis
Symptom relief CompletedThe proposed clinical trial aims to examine the efficacy of an online-based self-help intervention for auditory hallucinations in persons with psychotic disorders. The intervention is primarily based on Metacognitive Training (MKT) and Mindfulness-Based Group Therapy (MBGT). The …
Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Tiny particles in bleaching gel could mean whiter teeth and fewer zings
Symptom relief CompletedThe goal of this clinical trial is to learn the effect of Nano-fortified Bleaching on whitening and sensitivity of teeth.The main questions it aims to answer are: Does Nano-fortified Bleaching gel is more effective in enhancing the whitening in comparison to conventional bleachi…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Custom vaccine trains immune system to fight breast cancer
Vaccine Recruiting nowThis is a pilot protocol to evaluate the safety, feasibility, and immunogenicity of a personalized breast cancer vaccine based utilizing whole exome sequencing data of a patient's residual breast tumor following neoadjuvant chemotherapy.
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:02 UTC
-
Free meals and coaching aim to cut pregnancy risks
Prevention OngoingThe goal of this study is to learn whether access to healthy and fresh food, health coaching, and nutrition support intervention can reduce adverse birth outcomes in pregnant women. The main questions it aims to answer are: * Does access to healthy and fresh food, health coachin…
Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Heart rhythm showdown: ablation may beat defibrillator for some patients
Disease control Recruiting nowEvidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without cardiocirculatory arrest or syncope) is lacking, as no previous trials have included such patients. Additionally, sudden d…
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Double drug attack on ulcerative colitis shows promise
Disease control Recruiting nowThe main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. …
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple supplement slow ALS? new trial aims to find out
Disease control CompletedGenieUs developed an analysis platform that will be tested to separate study participants with ALS into four categories based on blood work. These general categories are neuroinflammation, oxidative stress, impaired autophagy \& axonal transport, and mitochondrial dysfunction. On…
Phase 2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Shocking the tongue to fix balance? new trial tests PoNS device in stroke patients
Disease control OngoingDouble blind, randomized, placebo controlled, interventional clinical trial investigating the efficacy and safety of PoNS therapy on improving dynamic gait and balance deficits in chronic stroke survivors.
Sponsor: Helius Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for lung cancer: first human trial of DZD6008 begins
Disease control Recruiting nowThis study is designed to evaluate safety and antitumor activity of DZD6008 in patients with advanced NSCLC with EGFR mutations. This is the first time the drug is tested in human.
Phase 1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Probiotic capsules take on bacterial vaginosis in major trial
Disease control CompletedPrimary Objective: To confirm that the clinical cure rate of Vaginal Lactobacillus Dual Probiotic Capsules for bacterial vaginosis (BV) is superior to placebo at the 21-30 day post-treatment visit (Day 21 to Day 30). Key Secondary Objective: To compare the clinical cure rate of …
Phase 3 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Immunotherapy side effect may be reversible: thyroid drug taper trial launches
Disease control Recruiting nowThe goal of this study is to find out whether hypothyroidism caused by immune checkpoint inhibitors (ICIs) can recover after stopping the ICIs. The study also aims to identify factors that can help predict which patients will be able to stop taking thyroid hormone replacement. T…
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Alzheimer's vaccine takes first step in human trial
Prevention CompletedThis Phase 1 clinical trial evaluates the safety, tolerability, and immune response of the adjuvanted AV-1959R vaccine in healthy adults aged 40-60. Participants will receive three intramuscular injections of either adjuvanted AV-1959R (100 µg or 300 µg) or adjuvanted placebo at …
Phase 1 • Sponsor: Nuravax, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
Can a Spur-Shaped stent fix Re-Blocked arteries?
Disease control CompletedTo demonstrate acceptable short term safety rates of the Drug-eluting Coronary Spur Stent System as a primary treatment for coronary in-stent restenosis.
Phase 1 • Sponsor: ReFlow Medical, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can your phone help you quit smoking? new study tests AR app
Symptom relief Recruiting nowThe overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can an ancient herbal mix tame psoriasis flares?
Disease control Recruiting nowPsoriasis is an inflammatory skin disease with huge negative impact on the quality of life of the patients, and has an overall prevalence of 2% to 3% in the general population. Plaques psoriasis is the most common type of the disease and presents red, well demarcated, and silvery…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug aims to keep leukemia away after transplant
Disease control Recruiting nowThe purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib, in addition to the standard treatment on blood cancer with Allogeneic Hematopoietic Cell Transplantation (allo-HCT). This study plans to learn more about ziftome…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New trial aims to ease cancer Patients' breathlessness with tailored oxygen and relaxation techniques
Symptom relief Recruiting nowTo learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC